ID   Hep-2 TPFR
AC   CVCL_GZ00
DR   Wikidata; Q54882756
RX   PubMed=25962396;
CC   Problematic cell line: Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC   Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1906 ! HEp-2
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 05-10-23; Version: 10
//
RX   PubMed=25962396; DOI=10.3892/mmr.2015.3768;
RA   Govindan S.V., Kulsum S., Pandian R.S., Das D., Seshadri M.,
RA   Hicks W. Jr., Kuriakose M.A., Suresh A.;
RT   "Establishment and characterization of triple drug resistant head and
RT   neck squamous cell carcinoma cell lines.";
RL   Mol. Med. Rep. 12:3025-3032(2015).
//